Printer Friendly

CLIA '88 regs issued; all labs affected.

CLIA 188 test categories Laboratories can determine which level of regulatory scrutiny they will experience from CLIA 88 by checking the following list of test categories. Providing any or all tests in Level I or 11 earns admission to that proposed echelon of review. Waiver from certification (exempt) * Dipstick or tablet reagent urinalysis for these analytes:

Bilirubin Nitrites

Glucose Protein

Hemoglobin pH

Ketone Specific gravity

Leukocytes Urobilinogen * Fecal occult blood * Spun microhematocrit * Microscopic examination of:

Urine sediment

Pinworm preparation

Vaginal wet mount preparation * Ovulation test-visual color test for human luteinizing hormone * Whole blood clotting time * Urine pregnancy tests * Antistreptolysin O (ASO) screen slide card agglutination test * C reactive protein (CRP) screen-slide card agglutination test * Rheumatoid factor screen-slide card agglutination test * Gram stain (on discharges and exudates) * Infectious mononucleosis screen-slide card agglutination test * Potassium hydroxide (KOH) preparation on cutaneous scrapings * Erythrocyte sedimentation rate * Sickle cell screening-methods other than electrophoresis * Glucose screen whole blood dipstick method--visual color comparison * Semen analysis * Cholesterol screen-qualitative and semiquantitative determinations * Culture tor colony counts for urinary tract intection-not to include identification and susceptibility * Hemoglobin-not electrophoresis * White blood cell count * Red blood cell count * Hematocrit * Urea nitrogen (BUN) * Creatinine * Uric acid * Glucose * Direct streptococcai antigen test * All other tests
COPYRIGHT 1990 Nelson Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1990 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Clinical Laboratory Improvement Amendments of 1988
Publication:Medical Laboratory Observer
Date:Jul 1, 1990
Words:201
Previous Article:Controlling overutilization of the lab.
Next Article:Finding the diamond in the rough.
Topics:


Related Articles
Lab groups assess implementation of CLIA.
CLIA congress mounts comments to HCFA.
HCFA issues first round of revised lab regs.
HCFA advances CLIA '88 implementation.
CLIA issues help unify lab groups.
Lab regulators gain penalty options under CLIA sanctions.
CLIA '88 lurches ahead as Congress prods.
How to read the Federal Register and other CLIA-related documents.
CLIA's effect on POLs.
OIG solicits input on physician practice compliance guidelines and CLIAC discusses workforce shortages.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters